All Stories

  1. In Silico Study of Molecular Docking Between Lactoferrin and Autophagy‐apoptosis Genes ATG3, ATG5, and ATG12 and In Vitro Study of Lactoferrin Effect on These Gene Expressions in Breast Cancer
  2. MicroRNA-125b-5p Drives MMP-2 Expression via Activation of RAGE-38MAPK-p65/p50NF-κB Axis: A Novel Mechanism in Human Lung Cancer Cells
  3. In-silico identification and functional analysis of high-risk oncogenic nsSNPs in the human SDHB gene and their implications for cancer susceptibility
  4. Thymoquinone Upregulates microRNA-199a-3p and Downregulates COX-2 Expression and PGE2 Production via Deactivation of p38/ERK/JNK-MAPKs and p65/p50-NF-κB Signaling in Human Lung Cancer Cells
  5. Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  6. Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950–2023: a demographic analysis for the Global Burden of Disease Study 2023
  7. The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023
  8. Global, regional, and national burden of headache disorders, 1990–2021, with forecasts to 2050: A Global Burden of Disease study 2021
  9. Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage
  10. Global, regional, and national prevalence of kidney failure with replacement therapy and associated aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  11. Global burden of vision impairment due to age-related macular degeneration, 1990–2021, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021
  12. Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023
  13. Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019
  14. Comprehensive Review on Groundwater Exploitation, Depletion, and Its Management: Sustainable Approach Toward Agricultural Productivity in India
  15. Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study
  16. Global, regional, and national burden of household air pollution, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  17. Deciphering the Intricacies of Breast Cancer Signaling Network and the Potential of Soy-derived Isoflavones on Cancer Therapeutics
  18. Global, regional, and national burden of epilepsy, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  19. Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
  20. Global, regional, and national burden of asthma and atopic dermatitis, 1990–2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
  21. Micro-nano Plastics: Impact on Gastrointestinal System
  22. Global, regional, and national progress towards the 2030 global nutrition targets and forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021
  23. The Global Burden of Diarrheal Diseases: Causes, Risks, and Trends (1990–2021)
  24. Global, regional, and national stillbirths at 20 weeks' gestation or longer in 204 countries and territories, 1990–2021: findings from the Global Burden of Disease Study 2021
  25. Fermentation of soymilk with Lactobacillus acidophilus enhances the functional attributes and health-promoting properties
  26. Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  27. Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021
  28. Chemotherapeutic potential of lupeol against cancer in pre-clinical model: A systematic review and meta-analysis
  29. Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050
  30. Global, regional, and national burden of upper respiratory infections and otitis media, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021
  31. Global pattern, trend, and cross-country inequality of early musculoskeletal disorders from 1990 to 2019, with projection from 2020 to 2050
  32. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  33. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a syst...
  34. Burden of disease scenarios for 204 countries
  35. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  36. Unveiling the lead exposure attributed burden in Iran from 1990 to 2019 through the lens of the Global Burden of Disease study 2019
  37. Cold‐active microbial enzymes and their biotechnological applications
  38. Correction to: De novo transcriptome sequencing of drought tolerance–associated genes in little millet (Panicum sumatrense L.)
  39. Food Safety
  40. Global Health Trends 1950–2021: Impact of COVID-19 on Mortality and Population Growth
  41. Global, regional, and national burden of neck pain, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
  42. Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
  43. Physicochemical Characteristics and Antioxidant Activity of Some Algerian Extra Virgin Olive Oils (Olea europaea L.)
  44. Food Safety
  45. Microbial Pigments
  46. Implications of Asymptomatic Carriers for Tuberculosis Transmission and Control in Thailand: A Modelling Approach
  47. Microbial Vitamins and Carotenoids in Food Biotechnology
  48. Global Burden of Cardiovascular Diseases and Risks, 1990-2022
  49. National and subnational burden of leukemia and its risk factors, 1990–2019: Results from the Global Burden of Disease study 2019
  50. Drug-use disorders in the Eastern Mediterranean Region: a glance at GBD 2019 findings
  51. Mortality and disability-adjusted life years in North Africa and Middle East attributed to kidney dysfunction: a systematic analysis for the Global Burden of Disease Study 2019
  52. Advanced Food Waste Valorization Techniques for Bioenergy Production: A Path in the Direction of Environmental Sustainability
  53. Sensitivity and Selectivity Between Test Gases in Set (1) LPG, Ethanol, and Acetone and Set (2) NH3, Methanol, and NO2 of BaTiO3/Ag/WO3 Nanocomposite
  54. Selectivity of an Ag/BTO-Based Nanocomposite as a Gas Sensor Between NO2 and SO2 Gases
  55. Global and regional quality of care index (QCI) by gender and age in oesophageal cancer: A systematic analysis of the Global Burden of Disease Study 1990–2019
  56. Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019
  57. Global, regional, and national burden of rheumatoid arthritis, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
  58. The national trend of the burden of Chronic Kidney Disease (CKD) in Iran from 1990 to 2019
  59. De novo transcriptome sequencing of drought tolerance–associated genes in little millet (Panicum sumatrense L.)
  60. The levels and trends of metabolic risk factors in the elderly population at the national and sub-national scale in Iran from 1990 to 2016
  61. Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021
  62. Particulate Matter Pollution Remains a Threat for Cardiovascular Health: Findings From the Global Burden of Disease 2019
  63. Structure-Based Multi-Targeted Molecular Docking and Dynamic Simulation of Soybean-Derived Isoflavone Genistin as a Potential Breast Cancer Signaling Proteins Inhibitor
  64. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
  65. Electrochemical biosensors in healthcare services: bibliometric analysis and recent developments
  66. The burden of metabolic risk factors in North Africa and the Middle East, 1990–2019: findings from the Global Burden of Disease Study
  67. Diabetes: a defining disease of the 21st century
  68. Low bone mineral density, a neglected condition in North Africa and Middle East: estimates from the Global Burden of Disease Study, 1990–2019
  69. Effect of air pollution on disease burden, mortality, and life expectancy in North Africa and the Middle East: a systematic analysis for the Global Burden of Disease Study 2019
  70. Inferences on bioengineering perspectives and circular economy to tackle the emerging pollutants
  71. Hormesis-tempting stressors driven by evolutionary factors for mitigating negative impacts instigated over extended exposure to chemical elements
  72. Unlocking the microbial studies through computational approaches: how far have we reached?
  73. Advancements in the energy-efficient brine mining technologies as a new frontier for renewable energy
  74. Myconanotechnology and Application of Nanoparticles in Biology
  75. Value-Addition in Agri-food Industry Waste Through Enzyme Technology
  76. Value-Addition in Beverages through Enzyme Technology
  77. Estimating the burden of diseases attributable to lead exposure in the North Africa and Middle East region, 1990–2019: a systematic analysis for the Global Burden of Disease study 2019
  78. Regional burden of chronic kidney disease in North Africa and Middle East during 1990–2019; Results from Global Burden of Disease study 2019
  79. Nanotechnology for Nanophytopathogens: From Detection to the Management of Plant Viruses
  80. Integrated biorefinery development for pomegranate peel: Prospects for the production of fuel, chemicals and bioactive molecules
  81. MD Simulation Studies for Selective Phytochemicals as Potential Inhibitors against Major Biological Targets of Diabetic Nephropathy
  82. National, sub-national, and risk-attributed burden of thyroid cancer in Iran from 1990 to 2019
  83. Quality of care of peptic ulcer disease worldwide: A systematic analysis for the global burden of disease study 1990–2019
  84. Giardia lamblia infection and associated risk factors among patients attending Kochore Health Center, Ethiopia
  85. Knowledge, Attitude, and Practice of Community towards an Onchocerciasis Elimination Program from South West Ethiopia
  86. Bacterial bioactive metabolites as therapeutic agents: From production to action
  87. Burden of type 1 diabetes mellitus in the North Africa and Middle East Region, 1990–2019; findings from the global burden of disease study
  88. Nanocellulose in tissue engineering and bioremediation: mechanism of action
  89. The global, regional, and national burden and quality of care index (QCI) of colorectal cancer; a global burden of disease systematic analysis 1990–2019
  90. Editorial: Computational Genomics and Structural Bioinformatics in Microbial Science
  91. Identifying the alpha-glucosidase inhibitory potential of dietary phytochemicals against diabetes mellitus type 2 via molecular interactions and dynamics simulation
  92. Identifying Natural Therapeutics against Diabetes via Inhibition of Dipeptidyl Peptidase 4: Molecular Docking and MD Simulation Study
  93. Molecular Diagnosis, Antimicrobial Resistance Profiles and Disease Patterns of Gram-Positive Pathogens Recovered from Clinical Infections in Major Ha’il Hospitals
  94. Prevalence and Associated Risk Factors of Entamoeba Histolytica Infection Among Schoolchildren From Three Primary Schools In Arsi Town, West Zone, Ethiopia
  95. Microbial Extremozymes
  96. Front Matter
  97. Global impact of trace non-essential heavy metal contaminants in industrial cannabis bioeconomy
  98. Exploring the therapeutic potential of marine-derived bioactive compounds against COVID-19
  99. Assessment of bio-contaminants during COVID-19 outbreak from the indoor environment of Hail city, Kingdom of Saudi Arabia
  100. Interactions of linagliptin, rabeprazole sodium, and their formed complex with bovine serum albumin: Computational docking and fluorescence spectroscopic methods
  101. Prevalence and Risk Factor of Gastro-esophageal Reflux Disease among Hail Population, Saudi Arabia
  102. COLD-ACTIVE MICROBIAL CELLULASE: NOVEL APPROACH TO UNDERSTAND MECHANISM AND ITS APPLICATIONS IN FOOD AND BEVERAGES INDUSTRY
  103. Bioplastics for Sustainable Development
  104. Association between Human Health and Indoor Air Pollution in Saudi Arabia: Indoor Environmental Quality Survey
  105. Enzymatic potential for the valorization of agro-industrial by-products
  106. ELECTROCHEMICAL BIOSENSOR FOR FOOD BORNE PATHOGENS: AN OVERVIEW
  107. Modelling the transmission dynamics of COVID-19 in six high burden countries
  108. Green Nanomaterials for Wastewater Treatment
  109. Degradation of Organic Compounds by the Applications of Metal Nanocomposites
  110. Evaluation of vegetables and fish oils for the attenuation of diabetes complications
  111. Enzymes in Food Biotechnology
  112. A novel, thermotolerant, extracellular PHB depolymerase producer Paenibacillus alvei PHB28 for bioremediation of biodegradable plastics
  113. Enzymes in Food Technology
  114. Advancements in Applications of Surface Modified Nanomaterials for Cancer Theranostics
  115. Enzymatic degradation of PHB
  116. Bioremediation of bioplastics
  117. Oxidative stress and cholinesterase depression among farm workers occupationally exposed to pesticides in India
  118. Strain improvement studies on Microbacterium foliorum GA2 for production of α-amylase in solid state fermentation: Biochemical characteristics and wash performance analysis at low temperatures
  119. Statistical optimization of cold-active chitinase production by mutagenized cells of multi-enzyme producing Bacillus cereus GA6
  120. Production of C-phycocyanin and its potential applications
  121. Bio-statistical approach for optimization of cold-active α-amylase production by novel psychrotolerant M. foliorum GA2 in solid state fermentation
  122. Production of laccase from newly isolated Pseudomonas putida and its application in bioremediation of synthetic dyes and industrial effluents
  123. Isolation of novel chitinolytic bacteria and production optimization of extracellular chitinase
  124. Seasonal variations in cholinesterase activity, nerve conduction velocity and lung function among sprayers exposed to mixture of pesticides
  125. Drug–DNA interaction: A theoretical study on the binding of thionine with DNAs of varying base composition
  126. Cannabis sativa: An ancient wild edible plant of India
  127. Recent Developments in Production and Biotechnological Applications of C-Phycocyanin
  128. Trans-resveratrol restores the damages induced by organophosphate pesticide-monocrotophos in neuronal cells
  129. Visual disturbances with cholinesterase depletion due to exposure of agricultural pesticides among farm workers
  130. Recent developments in production and biotechnological applications of cold-active microbial proteases
  131. Cold-active extracellular α-amylase production from novel bacteria Microbacterium foliorum GA2 and Bacillus cereus GA6 isolated from Gangotri glacier, Western Himalaya
  132. Structural adaptation and biocatalytic prospective of microbial cold-active α-amylase
  133. Cholinesterase levels and morbidity in pesticide sprayers in North India
  134. Production optimization of an extracellular cold-active alkaline protease from Stenotrophomonas maltophilia MTCC 7528 and its application in detergent industry
  135. An Overview of Cold-active Microbial α-amylase: Adaptation Strategies and Biotechnological Potentials
  136. Nerve conduction studies in sprayers occupationally exposed to mixture of pesticides in a mango plantation at Lucknow, North India
  137. Cold-active extracellular alkaline protease from an alkaliphilicStenotrophomonas maltophilia: production of enzyme and its industrial applications
  138. A cold-active extracellular metalloprotease from Curtobacterium luteum (MTCC 7529): Enzyme production and characterization